Skip to main content
. Author manuscript; available in PMC: 2010 Jul 1.
Published in final edited form as: Cancer Res. 2009 Jun 23;69(13):5601–5609. doi: 10.1158/0008-5472.CAN-08-3860

Table 1.

Proteins identified by mass spectrometry were analyzed by MetaCore software (GeneGo Inc.) using two algorithms in which the output is either an intracellular signaling pathway or a biological process. Significance was defined as p<0.05.

Pathway models LacZ (−log P) MyrAktl (−logP)
Translation: Elongation: Termination 3.9 (n/s)
Cytoskeleton: Regulation of cytoskeleton rearrangement (n/s) 4.7
Cell cycle: Meiosis (n/s) 5.9
Cytoskeleton: Cytoplasm microtubules (n/s) (n/s)
Inflammation: IL-6 signaling (n/s) 4.1
DMA damage: Check point (n/s) 4.1
Inflammation: TREMI signaling (n/s) 3.9
Cell cycle: GI-S (n/s) 3.6
Cell adhesion: Cell junctions (n/s) 3.6
Transduction: Translation initiation 4.5 (n/s)
 Biological process models LacZ (−log P) MyrAktl (−logP)
Glycolysis and gluconeogenesis (n/s) (n/s)
Vitamin K metabolism (n/s) (n/s)
Transcription: Role of heterochromatin protein(HPI) family in transcriptional silencing (n/s) 1.5
Cell cycle: Role of 14-3-3 proteins in cell cycle regulation (n/s) 5.7
Translation: Regulation of translation initiation 1.6 (n/s)
Cytoskeleton remodeling: Neurofilament (n/s) (n/s)
Glycolysis and gluconeogenesis (n/s) (n/s)
Transcription: Role of AP in regulation of cellular metabolism (n/s) (n/s)
Cell cycle: Spindle assembly and chromosome separation (n/s) (n/s)
Development: Role of CDKS in neuronal development (n/s) (n/s)

n/s: not significant